These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
581 related items for PubMed ID: 28939389
1. Recombinant allergen and peptide-based approaches for allergy prevention by oral tolerance. Campana R, Huang HJ, Freidl R, Linhart B, Vrtala S, Wekerle T, Karaulov A, Valenta R. Semin Immunol; 2017 Apr; 30():67-80. PubMed ID: 28939389 [Abstract] [Full Text] [Related]
2. Epitope peptides and immunotherapy. Tanabe S. Curr Protein Pept Sci; 2007 Feb; 8(1):109-18. PubMed ID: 17305564 [Abstract] [Full Text] [Related]
10. Recombinant allergens for immunotherapy: state of the art. Zhernov Y, Curin M, Khaitov M, Karaulov A, Valenta R. Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):402-414. PubMed ID: 31082821 [Abstract] [Full Text] [Related]
11. Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy. Prickett SR, Rolland JM, O'Hehir RE. Clin Exp Allergy; 2015 Jun; 45(6):1015-26. PubMed ID: 25900315 [Abstract] [Full Text] [Related]
12. Prospects for peptide-based immunotherapy for dog allergy. Virtanen T. Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):461-5. PubMed ID: 17088652 [Abstract] [Full Text] [Related]
13. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity. Focke M, Swoboda I, Marth K, Valenta R. Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812 [Abstract] [Full Text] [Related]
14. Regulation of specific immune responses by chemical and structural modifications of allergens. Akdis CA, Blaser K. Int Arch Allergy Immunol; 2000 Apr; 121(4):261-9. PubMed ID: 10828716 [Abstract] [Full Text] [Related]
15. Molecular Aspects of Allergens and Allergy. Valenta R, Karaulov A, Niederberger V, Gattinger P, van Hage M, Flicker S, Linhart B, Campana R, Focke-Tejkl M, Curin M, Eckl-Dorna J, Lupinek C, Resch-Marat Y, Vrtala S, Mittermann I, Garib V, Khaitov M, Valent P, Pickl WF. Adv Immunol; 2018 Apr; 138():195-256. PubMed ID: 29731005 [Abstract] [Full Text] [Related]
16. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future. Valenta R, Campana R, Focke-Tejkl M, Niederberger V. J Allergy Clin Immunol; 2016 Feb; 137(2):351-7. PubMed ID: 26853127 [Abstract] [Full Text] [Related]
17. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance. Berings M, Karaaslan C, Altunbulakli C, Gevaert P, Akdis M, Bachert C, Akdis CA. J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667 [Abstract] [Full Text] [Related]
19. The Molecular Allergen Recognition Profile in China as Basis for Allergen-Specific Immunotherapy. D'souza N, Weber M, Sarzsinszky E, Vrtala S, Curin M, Schaar M, Garib V, Focke-Tejkl M, Li Y, Jones R, Chen H, Valenta R, Sun B. Front Immunol; 2021 Oct; 12():719573. PubMed ID: 34512644 [Abstract] [Full Text] [Related]
20. Peptide and recombinant immunotherapy. Larché M. Immunol Allergy Clin North Am; 2011 May; 31(2):377-89, xi. PubMed ID: 21530826 [Abstract] [Full Text] [Related] Page: [Next] [New Search]